Robert Bitterman, President & CEO, Director at Phio Pharmaceuticals, holds 18.99K shares in Phio Pharmaceuticals (Ticker: PHIO), holds 0.00 shares in Fibrocell Science (Ticker: FCSC). Most recently, Robert Bitterman Bought ― shares of Phio Pharmaceuticals on Feb 27, 2024 for an estimated value of 2.27K.